XNAS · ILMN

-1.59% · -$3.02 · Vol 1.9M

Market closed · last close 4:00 PM ET · price as of 17:23:47 ET

Illumina Inc

LABORATORY ANALYTICAL INSTRUMENTS

$187.03

+ Add to watchlist

Card

Relationship Map

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is ILMN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move ILMN next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 14
Score
Score moved +3
60/NEUTRAL -> 63/BUY BIAS
Veridion score historySource
Mar 9
CongressSovereign
Gilbert Cisneros purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Mar 9
CongressSovereign
Hon. Gilbert Cisneros sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Feb 6
CongressSovereign
Ro Khanna sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Nov 21
CongressSovereign
Lisa Mcclain sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Nov 21
CongressSovereign
Lisa Mcclain purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Aug 13
CongressSovereign
Lisa Mcclain purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Apr 18
CongressSovereign
Thomas H. Kean Jr purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt

Catalyst calendar

Dated receipts for ILMN are being assembled.

About Illumina Inc

LABORATORY ANALYTICAL INSTRUMENTS

Listed since

2000

Employees

Country

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$189.17

Day high

$194.18

Day low

$187.09

Previous close

$190.05

52W high

$194.18

-3.68% from high

52W low

$187.03

0% of range

Market cap

$28.8B

P/E

44.96×

EPS

$4.16

Shares out

151.3M

Volume

1.9M

VWAP

$191.03

Price history computed in-house

-1.67%

SMA 50 $189.80 · below

SMA 200 $189.80 · below

52W position 0%

Veridion warehouse edge

Warehouse intelligence for ILMN.

Veridion Score

0: 321: 402: 783: 524: 685: 70

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Related public evidence

Relationship mapTrace receipt-backed holders and filings around ILMN.Congress disclosuresOpen receipt and filing context for ILMN.Thematic mapTechBio & AI Drug Discovery MethodologyReview score inputs, coverage rules, and limitations.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

ILMN insider activity

Illumina Inc

Score

Coverage building

Pressure

Mixed

Filings

Buys / sells

0 / 0

Net value

Not disclosed

Insiders

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ILMN.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

ILMN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for ILMN in this window.

Lobbying spend

ILMN lobbying filings, year to date.

Registered lobbying filings matched to Illumina Inc.

$930.0K

Refresh interval: 12hSource: LDA disclosure filings

Budget/Appropriations Health Issues Homeland Security Medicare/Medicaid Trade (domestic/foreign)Health Issues Medicare/Medicaid Trade (domestic/foreign)Manufacturing Energy/Nuclear Taxation/Internal Revenue Code

Filing

$330.0K

ILLUMINA INC.

ILLUMINA, INC.

Jan 20, 2026

Filing

$320.0K

ILLUMINA INC.

ILLUMINA, INC.

Apr 20, 2026

Filing

$120.0K